Heinz Läubli Selected Research

Heinz Läubli Research Topics

Disease

44	Neoplasms (Cancer) 01/2022 - 02/2006
8	Melanoma (Melanoma, Malignant) 07/2021 - 01/2015
6	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2006
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2020 - 01/2015
6	Inflammation (Inflammations) 01/2019 - 06/2010
3	Lung Neoplasms (Lung Cancer) 10/2019 - 01/2018
2	Glioma (Gliomas) 01/2022 - 06/2020
2	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 06/2020
2	Carcinogenesis 10/2020 - 10/2019
2	Autoimmune Diseases (Autoimmune Disease) 02/2020 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 10/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2019 - 01/2015
2	Pneumonia (Pneumonitis) 01/2018 - 01/2018
1	Tertiary Lymphoid Structures 07/2021
1	Lymphoma (Lymphomas) 02/2021
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Hodgkin Disease (Hodgkin's Disease) 11/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2019
1	Hypoparathyroidism 01/2019
1	Colitis 01/2019
1	Hypocalcemia 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 11/2018
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018
1	Organizing Pneumonia 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Adenocarcinoma 01/2017
1	Central Nervous System Vasculitis 01/2017
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2016
1	Myocarditis (Carditis) 01/2015
1	Heart Failure 01/2015
1	Uveal melanoma 01/2015

Drug/Important Bio-Agent (IBA)

12	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
12	AntibodiesIBA 01/2021 - 01/2014
11	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2022 - 09/2014
9	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2021 - 01/2014
7	LigandsIBA 01/2019 - 02/2006
6	SelectinsIBA 10/2020 - 02/2006
5	AntigensIBA 07/2021 - 01/2014
5	Polysaccharides (Glycans)IBA 12/2020 - 01/2015
4	NivolumabIBA 07/2019 - 01/2015
3	ChemokinesIBA 01/2022 - 06/2010
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	Blocking AntibodiesIBA 01/2021 - 01/2018
3	LectinsIBA 10/2020 - 11/2014
3	CarbohydratesIBA 10/2020 - 06/2010
3	Sialic AcidsIBA 10/2019 - 02/2016
3	L-SelectinIBA 06/2010 - 02/2006
2	pembrolizumabIBA 07/2019 - 01/2015
2	Uncoupling Protein 2IBA 04/2019 - 01/2019
2	IpilimumabIBA 01/2019 - 01/2015
2	IntegrinsIBA 01/2019 - 06/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2015
2	E-SelectinIBA 06/2010 - 02/2010
2	P-SelectinIBA 06/2010 - 02/2006
1	larotrectinibIBA 01/2022
1	GlycosaminoglycansIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2022
1	Lymphotoxin-alpha (Lymphotoxin)IBA 07/2021
1	Interleukin-10 (Interleukin 10)IBA 07/2021
1	atezolizumabIBA 02/2021
1	CytokinesIBA 02/2021
1	CTLA-4 AntigenIBA 01/2021
1	Neuraminidase (Sialidase)IBA 12/2020
1	HexosaminesIBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Bevacizumab (Avastin)FDA Link 06/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2020
1	Temozolomide (Temodar)FDA LinkGeneric 06/2020
1	4-(4-sulfophenylazo)-2-mercuriphenol (SAMP)IBA 02/2020
1	LipidsIBA 10/2019
1	Immunoconjugates (Immunoconjugate)IBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	PhosphoproteinsIBA 10/2019
1	KIR ReceptorsIBA 01/2019
1	Extracellular Matrix ProteinsIBA 01/2019
1	Parathyroid Hormone (Parathormone)IBA 01/2019
1	Cell Adhesion MoleculesIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	PlatinumIBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	VaccinesIBA 01/2018
1	Axitinib (AG 013736)IBA 01/2018
1	Infliximab (Remicade)FDA Link 01/2018
1	Neutralizing AntibodiesIBA 01/2018
1	AutoantibodiesIBA 01/2017
1	Lenalidomide (CC 5013)FDA Link 01/2016
1	Costimulatory and Inhibitory T-Cell ReceptorsIBA 01/2015
1	Carrier Proteins (Binding Protein)IBA 11/2014
1	Cell ExtractsIBA 11/2014
1	Monoclonal AntibodiesIBA 04/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2014

Therapy/Procedure

22	Immunotherapy 01/2022 - 01/2014
13	Therapeutics 01/2022 - 01/2015
1	Radiotherapy 06/2020
1	Drug Therapy (Chemotherapy) 01/2018
1	Immunomodulation 11/2014